HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The phosphorylation status of merlin in sporadic vestibular Schwannomas.

Abstract
The events leading to Schwannomas development are still largely unknown. Some studies have demonstrated that merlin acts as a tumor suppressor by blocking Ras-mediated signaling. In this study, we analyze the clinical and biological behaviors of seven randomly selected sporadic vestibular Schwannomas removed from the patients. We find that merlin was commonly lost in these Schwannomas, due to loss of merlin expression or phosphorylation status of merlin expression. Heightened CDKs/cyclins signal transduction concomitant with loss of p27 was well correlated with loss of functional merlin in Schwannomas. More, we show that phosphorylated merlin Schwannomas exhibited increased Ras/Rac/PAK signal transduction. That was in agreement with the severe clinical behaviors, i.e., phosphorylation status of merlin increased tumor size in sporadic vestibular Schwannomas. These results led us to suggest that phosphorylated merlin, a kind of type of mutation merlin, is involved in tumorigenesis of sporadic vestibular Schwannomas.
AuthorsZhaoyan Wang, Yanjun Lu, Juanjuan Tang, Haojie Wang, Hao Wu
JournalMolecular and cellular biochemistry (Mol Cell Biochem) Vol. 324 Issue 1-2 Pg. 201-6 (Apr 2009) ISSN: 1573-4919 [Electronic] Netherlands
PMID19142715 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cyclins
  • Neurofibromin 2
  • Cyclin-Dependent Kinase Inhibitor p27
  • Cyclin-Dependent Kinases
  • ras Proteins
Topics
  • Adult
  • Cyclin-Dependent Kinase Inhibitor p27 (deficiency)
  • Cyclin-Dependent Kinases (metabolism)
  • Cyclins (metabolism)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neurofibromin 2 (analysis, metabolism)
  • Neuroma, Acoustic (chemistry, etiology, pathology)
  • Phosphorylation
  • Signal Transduction
  • Tumor Burden
  • Young Adult
  • ras Proteins (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: